drugset / Trial / NCT00552422

Domperidone for Gastroparesis in Solid Organ Transplantation

NCT00552422

Terminated 6 enrolled David J. Lederer, M.D.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to examine the clinical response to domperidone in solid organ transplant recipients with gastroparesis.

Timeline

Start
2007-03
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Domperidone Unknown 10 mg Oral